✦ LIBER ✦

Clinical use of topoisomerase I inhibitors in anticancer treatment

✍ Scribed by Rodriguez-Galindo, Carlos ;Radomski, Kristine ;Stewart, Clinton F. ;Furman, Wayne ;Santana, Victor M. ;Houghton, Peter J.

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 167 KB
Volume: 35
Category: Article
ISSN: 0098-1532
DOI: 10.1002/1096-911x(20001001)35:4<385::aid-mpo1>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical use of aromatase inhibitors in

Clinical use of aromatase inhibitors in the treatment of breast cancers

✍ Andrea Manni 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB 👁 1 views

Estrogens are the major hormones supporting the growth of human breast cancer. Aromatization of androgen precursors in peripheral tissues, including the breast cancer itself, is the major source of estrogens in postmenopausal women. Therefore, inhibition of the aromatase enzyme offers an effective m

ChemInform Abstract: Recent Developments

ChemInform Abstract: Recent Developments in the Synthesis of Indolocarbazoles, Topoisomerase I Inhibitors

✍ M. Prudhomme; F. Anizon; P. Moreau 📂 Article 📅 2000 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

Clinical predictors of response to acety

Clinical predictors of response to acetyl cholinesterase inhibitors: experience from routine clinical use in Newcastle

✍ S. Pakrasi; E. B. Mukaetova-Ladinska; I. G. McKeith; J. T. O'Brien 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## Background Acetyl Cholinesterase Inhibitors (AChEIs) have been in clinical use for the past five years in the UK for the symptomatic treatment of Alzheimer's disease (AD). There are few data on the patterns and predictors of response to AChEI therapy in routine clinical practice. We

The development of composite circulating

The development of composite circulating biomarker models for use in anticancer drug clinical development

✍ Lee J. Lancashire; Darren L. Roberts; Caroline Dive; Andrew G. Renehan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 373 KB

## Abstract The development of informative composite circulating biomarkers predicting cancer presence or therapy response is clinically attractive but optimal approaches to modeling are as yet unclear. This study investigated multidimensional relationships within an example panel of serum insulin‐

Catechol-O-methyltransferase inhibitors:

Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

✍ Jasper Dingemanse 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 2 views

Substitution therapy with levodopa and a peripheral inhibitor of aromatic L-amino acid decarboxylase (AADC) is the cornerstone in the treatment of Parkinson's disease. Chronic therapy with levodopa, however, is associated with the occurrence of motor complications that are partially related to the p

ChemInform Abstract: Synthesis of New Di

ChemInform Abstract: Synthesis of New Dihydroindeno[1,2-c]isoquinoline and Indenoisoquinolinium Chloride Topoisomerase I Inhibitors Having High in vivo Anticancer Activity in the Hollow Fiber Animal Model.

✍ Muthusamy Jayaraman; Brian M. Fox; Melinda Hollingshead; Glenda Kohlhagen; Yves 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 41 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v